Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod and Intradermal QIV in Elderly and Chronically Ill Subjects
NCT04143451Phase 3Unknown
- Sponsor
- The University of Hong Kong
- Start
- Oct 2019
- Primary completion
- Sep 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of imiquimod in influenza, sponsored by The University of Hong Kong. Status: unknown.
02
Drugs
imiquimod
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04143451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04143451.